Acadia Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc. Beats on EPS, Stock Up 1.02%

ACADIA Pharmaceuticals reported a narrower-than-expected loss per share, which contributed to a positive stock reaction, with shares rising by 1.02%. However, there was no revenue data provided, and no guidance updates were issued. Investors may be cautiously optimistic about the company's performance based on the EPS surprise, but the lack of additional information leaves some uncertainty.